Pneumonia Pneumosistis

I Wayan Gustawan, BNP Arhana, Putu Siadi Purniti, IB Subanada, K Dewi Kumara Wati

Sari


Pneumonia pnemosistis merupakan penyebab kesakitan yang serius dan kematian pada kasus gangguan
sistem imun. Pneumonia pnemosistis merupakan infeksi oportunistik tersering pada kasus yang terinfeksi
HIV, leukemia dan anak yang menerima transplantasi organ. Organisme penyebab adalah Pneumocystis
carinii. Manifestasi klinis berupa gangguan pernapasan disertai penyakit dasarnya. Diagnosis pasti ditegakkan
dengan ditemukannya organisme dalam pemeriksaan mikroskopis. Pengobatan secara umum terdiri dari
tata laksana suportif dan spesifik. Trimetoprim-sulfametoksasol masih merupakan pilihan pertama baik
untuk terapi maupun profilaksis. Angka kematian masih tinggi, terutama yang terlambat mendapat terapi.


Kata Kunci


pneumonia; Pneumocystis carinii; HIV

Teks Lengkap:

PDF

Referensi


Hughes WT. Pneumocystis carinii. Dalam: Behrman RE,

Kliegman RM, Jenson HB, penyunting. Nelson textbook

of pediatrics. Edisi ke-17. Philadelphia: Saunders;

h. 1154-5.

Bellamy R. Pneumocystis pneumonia in people with

HIV. Clin Evid 2005; 13:1-16.

Morris A, Lundgren JD, Masur H, Walzer PD, Hanson

DL, Frederick T, dkk. Current epidemiology of pneumocystis

pneumonia. Emerg Infect Dis 2004; 10:1713-20.

Kaplan JE, Hanson D, Dworkin MS, Frederick T,

Bertolli J, Lindegren ML, dkk. Epidemiology of human

immunodeficiency virus–associated opportunistic epidemiology

of human immunodeficiency virus–associated

opportunistic therapy. Clinical Infectious Diseases

; 30:S5–14.

Hallett JJ, Fickenscher LG, Ablin AR. Pneumocystis

carinii pneumonia in children. Western J Med 1977;

:441-4.

Schreibman TS. Pneumocystis carinii pneumonia.

Emedicine. 2004 (diakses tanggal 5 Januari 2006).

Diproleh dari: URL:http://www.emedicine.com.

Miller RF, Wakefield AE. Pneumocystis carinii genotypes

and severity of pneumonia. Lancet 1999;

:2039-40.

Stringer JR, Beard CB, Miller RF, Wakefield AE. A new

name (Pneumocystis jiroveci) for pneumocystis from humans.

Emerg Infect Dis 2002; 8:891-6.

Thomas CF, Limper AH. Pneumocystis pneumonia.

New Engl J Med 2004; 350:2487-98.

Kovacs JA, Gill VJ, Meshnick S, Masur H. New insight

into transmission, diagnosis, and drug treatment of

pneumocystis carinii pneumonia. JAMA 2001; 286:2450-

Brooks GF, Butel JS, Morse, SA. Medical microbiology.

Edisi ke-23. Boston: McGraw Hill; 2004. h. 650-

Walzer PD. Pneumocystis carinii infection. Dalam:

Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper

DL, Jameson JL, penyunting. Principles of internal

medicine. Edisi ke-16. Boston: McGraw Hill; 2001. h.

-5.

Collier L, Balows A, Sussman M. Topley and Wilson’s

microbiology and microbial Infections. Edisi ke-9. New

York: Arnold Publishing; 1998. h. 674

Ryan KJ. Pneumocystis carinii. Dalam: Ryan KJ, Ray

CG, penyunting. Medical microbiology. Edisi ke-4. New

York: McGraw Hill; 2004. h. 685-9.

Rubin E. Essential pathology. Edisi ke-3. Philadelphia:

Lippincott Williams & Wilkins; 2001. h. 318.

Hughes WT. Pneumocystis carinii pneumonitis. Dalam:

Chernick V, Boat TF, Kendig EL, penyunting. Kendig’s

disorders ot the respiratory tract in children. Edisi ke 6.

Philadelphia: Saunders; 1998. h. 503-11.

Sattler F, Nichols L, Hirano L, Hiti A, Hofman F,

Hughlett C, dkk. Nonspecific interstitiel pneumonitis

mimicking Pneumocystis carinii pneumonia. Am J Respir

Crit Care Med 1997; 156:912-7.

Chow C, Templeton PA, White CS. Lung cysts associated

with Pneumocystis carinii pneumonia: radiographic

characteristics, natural history, and complications. AJR

; 161:527-31.

Hay WW, Levin MJ, Hayward AR, Sondheimer JM.

Current pediatric diagnosis & treatment. Edisi ke-16.

Boston: McGraw Hill; 2003. h. 1249-51.

Cruciani M, Marcati P, Malena M, Bosco O, Serpelloni

G, Mengoli C. Meta-analysis of diagnostic procedures

for Pneumocystis carinii pneumonia in HIV-1-infected

patients. Eur Respir J 2002; 20:982–9.

Teisa A, Tabaczka P. The use of polarization microscopy

in the diagnosis of pneumocystis pneumonia. Arch

Pathol Lab Med 2004; 128:363-4.

Ioannidis J, Wilkinson D. HIV: prevention of opportunistic

infections. Clin Evid 2005; 13:832-51.

Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O,

Bickel M, dkk. Discontinuation of secondary prophylaxis

against Pneumocystis carinii pneumonia in patients

with HIV infection who have a response to antiretroviral

therapy. New Engl J Med 2001; 344:168-74.

Hocker B, Wendt C, Nahimana A, Tonshoff B, Hauser

PM. Molecular evidence of Pneumocystis transmission

in pediatric transplant unit. Emerg Infect Dis 2005;

:330-2.

Masur H, Kaplan JE, Holmes KK. Guidelines for preventing

opportunistic infections among HIV-infected

persons—2002 Recommendations of the U.S. Public

Health Service and the Infectious Diseases Society of

America. Ann Intern Med. 2002; 137:435-77.

Centers for Disease Control and Prevention: 1995 Revised

guidelines for prophylaxis againts Pneumocystis

carinii pneumonia for children infected with or

perinatally exposed to human immunodeficiency virus.

MMWR 1995; 44(RR-4):1-18.

Furrer H, Egger M, Opravil M, Bernasconi E, Hirschel

B, Battegay M, dkk. Discontinuation of primary prophylaxis

against pneumocystis carinii pneumonia in HIV-

–infected adults treated with combination antiretroviral

therapy. N Engl J Med 1999; 240:1301-6.




DOI: http://dx.doi.org/10.14238/sp9.5.2008.328-34

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.